Premium
Relationship between improvements of subjective well‐being and depressive symptoms during acute treatment of schizophrenia with atypical antipsychotics
Author(s) -
Kim J.H.,
Ann J.H.,
Kim M.J.
Publication year - 2011
Publication title -
journal of clinical pharmacy and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.622
H-Index - 73
eISSN - 1365-2710
pISSN - 0269-4727
DOI - 10.1111/j.1365-2710.2010.01175.x
Subject(s) - schizophrenia (object oriented programming) , depressive symptoms , extrapyramidal symptoms , psychopathology , psychology , psychiatry , clinical psychology , atypical antipsychotic , psychosis , antipsychotic , cognition
What is known and Objective: It has been suggested that atypical antipsychotics may exert beneficial effects on subjective well‐being as well as depressive symptoms in schizophrenia. However, the relationship between the two remains to be clarified. The authors examined the relationship between subjective well‐being and depressive symptoms across the course of acute treatment with atypical antipsychotics in patients with schizophrenia. Methods: Thirty‐five inpatients with schizophrenia were examined for subjective well‐being, psychopathology, and extrapyramidal side effects before and 8 weeks after the initiation of new treatment with atypical antipsychotics. Results and Discussion: Significant improvement was observed in subjective well‐being, psychotic symptoms, and depressive symptoms. No change was observed in the severity of extrapyramidal side effect. The subjective well‐being score had significant negative correlations with depressive symptom score both at baseline and at week 8. The mean change in subjective well‐being score was significantly correlated with that in depressive symptom score. The severity of depressive symptoms at baseline was significantly correlated with the subsequent change in subjective well‐being score and the change in depressive symptom score was the only predictor of change in subjective well‐being score. What is new and Conclusion: Depressive symptoms were significantly associated with subjective well‐being in patients with schizophrenia and may moderate the acute effects of atypical antipsychotic treatment on subjective well‐being. Further investigations are necessary to fully define the place of depressive symptoms in the conceptualization of subjective well‐being in schizophrenia and the optimal use of atypical antipsychotics.